经皮腔内血管成形术治疗肘下严重手部缺血:系统综述
该系统综述评估经皮腔内血管成形术(PTA)治疗肘下阻塞性动脉疾病所致严重手部缺血(CHI)的安全性和有效性。纳入8项研究共176例患者,加权平均技术成功率为89.3%,临床成功率为69.9%,短期并发症率4.7%,5年一期和二期通畅率分别为38%和54%。结论认为PTA可行且技术成功率高、短期并发症低,但需长期对照研究进一步明确其临床获益。
要点
- PTA治疗肘下阻塞性动脉疾病所致CHI的技术成功率高(89.3%),短期并发症低(4.7%)。
- 临床成功率69.9%,5年一期通畅率38%,二期通畅率54%。
- 近20%患者需截肢,但96%为minor截肢(远端指骨或手指)。
核心结论
- PTA治疗肘下阻塞性动脉疾病所致CHI可行,技术成功率高且短期并发症率低。
- 需进一步长期对照研究明确血管内治疗相较于保守治疗或外科旁路的临床获益。
研究设计与样本
- 采用Newcastle-Ottawa量表评估非随机对照试验的偏倚,所有研究评分>5提示高质量。
主要发现
- 加权平均技术成功率为89.3%(范围82%-100%),临床成功率为69.9%(范围19%-100%),平均随访29.7±17.1个月。
- 短期(<30天)并发症率为4.7%,最常见包括穿刺点血肿、假性动脉瘤和桡动脉穿孔或再血栓形成。
- 近20%患者需截肢,其中96%为minor截肢(远端指骨或手指),仅2例需腕上截肢。
- 5年一期和二期通畅率分别为38%和54%,累积5年死亡率为33.1%。
临床怎么用
- 对于肘下阻塞性动脉疾病所致CHI,PTA可作为可行治疗选择,技术成功率高且短期并发症低。
局限性
- 缺乏长期对照研究,无法明确PTA相较于保守治疗或外科旁路的临床获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To perform a systematic review assessing the safety and efficacy of percutaneous transluminal angioplasty (PTA) for treatment of critical hand ischemia (CHI) due to below-the-elbow (BTE) obstructive arterial disease. MATERIALS AND METHODS: MEDLINE and EMBASE systematic searches were performed from inception to December 2020 to identify studies assessing PTA for management of BTE obstructive arterial disease. Three independent reviewers performed abstract selection, data extraction, and quality assessment. The Newcastle-Ottawa Scale was used to assess individual study bias for non-randomized controlled trials. RESULTS: Eight studies comprising 176 patients with obstructive BTE vessel disease were included. All studies had a score >5 on the Newcastle-Ottawa Scale, indicative of high quality. All studies used low-profile balloons (1.5-4 mm) for PTA of stenotic lesions or chronic total occlusions (CTOs). The weighted average technical success and clinical success rates were 89.3% (range = 82%-100%) and 69.9% (range = 19%-100%), respectively, at a mean follow-up of 29.7 ± 17.1 months. The short-term (<30 days) complication rate was low at 4.7% and most commonly included access site hematomas, pseudoaneurysms, and radial artery perforation or re-thrombosis. Nearly 20% of patients required an amputation, and most (96%) were minor (either distal phalanges or digits). Only 2 patients required above-wrist amputations. The primary and secondary patency rate at 5 years were 38% and 54%, respectively. The cumulative 5-year mortality rate was 33.1%. CONCLUSIONS: PTA for CHI due to BTE obstructive arterial disease is feasible with a high technical success rate and a low short-term complication rate. Additional long-term comparative studies are required to unequivocally establish the clinical benefit of endovascular treatment compared with conservative management or surgical bypass.
引用
- Awad El-Karim G, Kennedy SA, Ferraresi R, et al. Percutaneous Transluminal Angioplasty for Below-the-Elbow Critical Hand Ischemia: A Systematic Review. J Endovasc Ther. 2021. PMID: 34623191. doi:10.1177/15266028211050309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。